Cannabidiol for Fibromyalgia: Evidence-Based Cannabis Care
This CBD fibromyalgia clinical trial evaluated the efficacy of cannabidiol in reducing fibromyalgia pain. Results showed no superiority of CBD over placebo. These findings emphasize the need for cautious interpretation of CBD as a treatment option.
Cannabinoid Clinical Trials: Mental Health & Substance Use
Cannabinoids mental health studies highlight that current evidence does not firmly establish cannabinoids as effective primary treatments for most mental health or substance use disorders. Adverse effects were commonly reported, emphasizing clinical…
CBD Chewing Gum: A Plausible Idea With Very Little Clinical Proof
The CBD chewing gum clinical trial reveals no significant benefit over placebo, underscoring the need for more research. Despite its plausible drug delivery concept, clinical proof remains limited. Understanding the trial outcomes helps guide patient…
Cannabidiol in Anorexia Nervosa: A Double-Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change.
This pilot study evaluates cbd anorexia nervosa safety in a randomized, placebo-controlled trial. It focuses on tolerability and pharmacokinetics in affected women. The findings provide preliminary safety data for future research.
Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral
This randomized and blind evaluation investigates the efficacy of full-spectrum oral cannabis extract for chronic osteoarthritis pain. The study provides clinical evidence on pain relief potential. Results highlight the importance of full-spectrum oral…
Can Cannabis Replace Opioids for Chronic Pain? What We Know and What Remains Uncertain
This 2025 narrative review explores cannabinoid analgesia mechanisms and their role in chronic pain management. It highlights biological plausibility and clinical evidence supporting cannabinoids for neuropathic and arthritis pain. However, significant…
CBD Shows Promise But Lacks Broad Regulatory Approval: A Sobering Review of the Evidence
The CBD pharmacology regulatory context reveals a narrow evidence base supporting broad approval. Most CBD products lack pharmaceutical-grade quality and regulatory endorsement. This 2024 review highlights the need for rigorous clinical trials and…
Cannabis and Sleep: A Proposed Vicious Cycle That Urgently Needs Testing
The bidirectional cannabis sleep model proposes that sleep problems lead to cannabis self-medication, which may worsen sleep quality over time. This cycle can increase cannabis tolerance and escalate use, raising the risk of cannabis use disorder.…
Only Five Trials Found: Cannabinoids for Post-Surgery Pain Remain an Open Question
The focus on cannabinoids acute postoperative pain reveals only five trials with contradictory results. This scarcity of data prevents meta-analytic evaluations and clinical recommendations. More standardized research is essential to clarify their role…
CBD Chewing Gum: Promising Concept, Thin Evidence
CBD chewing gum drug delivery is a promising concept with limited clinical evidence. Research gaps remain in absorption mechanisms, dosing precision, and long-term safety. Current trials show no significant efficacy over placebo.